Company:  DARE BIOSCIENCE, INC. (DARE)
Form Type:  10-Q
Filing Date:  5/14/2018 
CIK:  0001401914 
Address:  3655 NOBEL DRIVE
SUITE 260
 
City, State, Zip:  SAN DIEGO, California 92122 
Telephone:  858-926-7655 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.93  
Change: 
-0.0195 (-2.05%)  
Trade Time: 
Nov 16  
Market Cap: 
$10.62M
Trade DARE now with

© 2018  
Description of Business
The terms "we," "us," "our," "Daré" or the "Company" refer collectively to Daré Bioscience, Inc. and its wholly-owned subsidiaries, unless otherwise stated or the context otherwise requires. All information presented in this report is based on our fiscal year. Unless otherwise stated, references to particular years, quarters, months or periods refer to our fiscal years ending December 31 and the associated quarters, months and periods of those fiscal years. Overview We are a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's reproductive health. We are driven by a mission to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health and fertility.
Register and access this filing in:     
  FORM 10-Q
    PART I ? FINANCIAL INFORMATION
      Item 1. Consolidated Financial Statements.
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        Notes to Consolidated Financial Statements (Unaudited)
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 3. Quantitative and Qualitative Disclosures About ...
      Item 4. Controls and Procedures
    PART II. OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 3. Defaults Upon Senior Securities
      Item 4. Mine Safety Disclosures
      Item 5. Other Information
      Item 6. Exhibits
    Signatures
  EXHIBIT 31.1
    CERTIFICATIONS
  EXHIBIT 31.2
    CERTIFICATIONS
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,